News & Press

Medical Advisory Board

Ritter Pharmaceuticals is supported by a team of advanced scientists, medical experts and researchers in the fields of gastroenterology, biotechnology, pharmacology, clinical laboratory medicine and nutritional sciences.

Dennis Savaiano, Ph.D.
Professor of Foods & Nutrition and Former Dean
at Purdue University

Dr. Savaiano has researched lactose intolerance for the past 20 years, where he has attempted to identify the dietary factors that can improve lactose tolerance. Formerly, he served as the associate dean and assistant director of the Agricultural Experiment Station Human Ecology at the University of Minnesota. Dr. Savaiano is a native Californian with degrees from Claremont McKenna College (BA in Biology) and the University of California at Davis (MS and PhD in Nutrition). He was a Professor in the Department of Food Science and Nutrition at the University of Minnesota from 1980 through 1995, and moved to Purdue University in 1995.

William J. Sanborn, M.D.
Chief, Division of Gastroenterology and Director at University of California San Diego

Dr. Sandborn serves as the Chief, Division of Gastroenterology and Director at University of California San Diego Inflammatory Bowel Disease Center and Professor of Clinical Medicine. Dr. Sandborn directs a large clinical research unit devoted to the conduct of clinical trials in inflammatory bowel disease, where he supervises a multi-investigator team of physicians, research fellows, nurses, and study coordinators. With his physician collaborators, he evaluates and develops new diagnostic modalities and medical therapies for inflammatory bowel disease. He is internationally recognized for his contributions in the fields of biotechnology therapy, clinical pharmacology, conduct of clinical trials, diagnostic and treatment of pouchitis, epidemiology and natural history, and endoscopic and radiographic imaging techniques. He has published more than 408 articles including articles in the New England Journal of Medicine, the Lancet, JAMA, the Annals of Internal Medicine, and Gastroenterology. His research includes clinical development and clinical pharmacology related to inflammatory bowel disease. From April 1993 to December 2010, Dr. Sandborn was head of the Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN and from January 2011 to present, the Division of Gastroenterology, University of California San Diego, La Jolla. Dr. Sandborn is extremely well regarded and well known within the investment community and is considered one of the key leading gastroenterologists in the United States for pharmaceutical research and clinical trial work.


William Chey, M.D.
Nostrant Professor of Gastroenterology & Nutrition Sciences, Director of the GI Physiology Laboratory, and Co-Director of the Michigan Bowel Control Program at Michigan Medicine

Dr. Chey is Nostrant Collegiate Professor of Gastroenterology & Nutrition Sciences, Director of the GI Physiology Laboratory, and Co-Director of the Michigan Bowel Control Program at Michigan Medicine. He also serves as a member of the Board of Trustees of the American College of Gastroenterology, the Board of Directors of the Rome Foundation and a member of the Advisory Board of the International Foundation of Functional GI Disorders. Dr. Chey has authored more than 300 manuscripts, reviews and book chapters, and he was the Co-Editor-in-Chief of the American Journal of Gastroenterology from 2010 to 2015. He has been elected to “Best Doctors” since 2001 and “America’s Top Doctors” since 2009. Dr. Chey has been inducted into the Clinical Excellence Society of the Department of Medicine, received the Dean’s Outstanding Clinician Award, was inducted into the League of Research Excellence at the University of Michigan and has received the Distinguished Clinician Award from the American Gastroenterological Association. Dr. Chey received his B.A. from the University of Pennsylvania and medical degree and training in internal medicine at the Emory University School of Medicine, completing his fellowship in gastroenterology at the University of Michigan.

Anthony Lembo, M.D.
Director, GI Motility and Functional Bowel Disorder Center at Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School.

Dr. Lembo is Director, GI Motility and Functional Bowel Disorder Center at Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School. He also serves as an active member of many professional societies including the American Gastroenterological Association, the American Neurogastroenterology and Motility Society, and the American College of Gastroenterology. Dr. Lembo’s research interests focus on functional bowel disorders such as irritable bowel syndrome, chronic constipation, and the placebo response. He has published extensively in leading peer-reviewed journals including Gastroenterology, Neurogastroenterology and Motility, Alimentary Pharmacology & Therapeutics, and Clinical and Translational Gastroenterology. Dr. Lembo received his M.D. from Tufts University School of Medicine.

Todd Klaenhammer, Ph.D.
Director of the Southeast Dairy Foods Research Center and Distinguished Professor - Food Microbiology, Genetics, Genomics at North Carolina State University

Todd R. Klaenhammer obtained degrees in Microbiology (B.S), and Food Science (M.S. & Ph.D) from the University of Minnesota. In 1978, he joined the North Carolina State University and currently holds faculty appointments in the Departments of Food, Bioprocessing and Nutrition Sciences; and in the Departments of Microbiology and Genetics. His group has published over 270 articles on dairy lactic acid bacteria, their bacteriophages, and probiotic cultures and their genomic traits. Todd is Fellow in the American Association for the Advancement of Science, the American Academy of Microbiology, the Institute of Food Technologists, and the American Dairy Science Association. In 2001, he was elected into the National Academy of Sciences. In 2009, the Board of Governors of the 17 Campus University of North Carolina System, awarded his group the prestigious O. Max Gardner award for excellence in research across the entire system. In 2010, the International Dairy Federation awarded his group the 2010 Eli Metchnikoff Award in Biotechnology and in 2015, the Japan Bifidus Foundation awarded Todd the Tissier Medal for work on probiotic lactic acid bacteria.

Byron L. Cryer, M.D.
Professor of Internal Medicine - Digestive and Liver Diseases and an Associate Dean at Southwestern Medical School, University of Texas Southwestern

Byron L. Cryer, MD, obtained his BA degree from Harvard College, Cambridge, MA, in 1982, and his medical degree from Baylor College of Medicine, Houston, TX, in 1986, where he also completed his internal medicine residency training from 1986 to 1989. Dr. Cryer obtained his gastroenterology fellowship training at The University of Texas Southwestern Medical Center at Dallas (1989-92), where he has remained as a member of the gastroenterology faculty.

Dr. Cryer's clinical interests are in general gastroenterology. His specific areas of interest are acid-peptic diseases of the upper gastrointestinal tract. Specific disease states of interest are Helicobacter pylori-induced ulcer disease and nonsteroidal anti-inflammatory drug-induced ulcers.

Dr. Cryer’s primary research interest has been in the pathogenesis of peptic ulcer disease. His research focus has been clinically oriented in that he has exclusively studied the pathophysiology of these processes in humans. Recent investigations have explored the mechanism of gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs) within the stomach and duodenum. The most recent aspect of NSAID investigation has been an evaluation of the cyclooxygenase (COX)-2 specific NSAIDs.

Within the AGA, Dr. Cryer has held many leadership positions. He is the past chair of the AGA Underrepresented Minorities Committee and a prior member of the AGA International Committee, AGA Institute Research Policy Committee, and AGA Institute Education and Training Committee. He has also led several AGA-sponsored public awareness campaigns to reduce the GI risks of NSAIDs and other commonly taken pain medications. Dr. Cryer currently holds the position of councillor-at-large on the AGA Institute Governing board.

Featuring Recent Posts WordPress Widget development by YD